{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:27:06Z","timestamp":1792193226879,"version":"4.4.0"},"reference-count":20,"publisher":"The Endocrine Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Background: Many girls with Turner syndrome (TS) are treated with GH to increase adult height. In addition to promoting longitudinal bone growth, GH has effects on bone and body composition.<\/jats:p>\n                  <jats:p>Objective: The objective was to determine how GH treatment affects bone mineral density (BMD) and body composition in girls with TS.<\/jats:p>\n                  <jats:p>Method: In a cross-sectional study, we compared measures of body composition and BMD by dual energy x-ray absorptiometry, and phalangeal cortical thickness by hand radiography in 28 girls with TS who had never received GH and 39 girls who were treated with GH for at least 1 yr. All girls were participants in a National Institutes of Health (NIH) Clinical Research Center (CRC) protocol between 2001 and 2006.<\/jats:p>\n                  <jats:p>Results: The two groups were similar in age (12.3 yr, sd 2.9), bone age (11.5 yr, sd 2.6), and weight (42.8 kg, sd 16.6); but the GH-treated group was taller (134 vs. 137 cm, P = 0.001). The average duration of GH treatment was 4.2 (sd 3.2) yr (range 1\u201314 yr). After adjustment for size and bone age, there were no significant differences in BMD at L1\u2013L4, 1\/3 radius or cortical bone thickness measured at the second metacarpal. However, lean body mass percent was higher (P &amp;lt; 0.001), whereas body fat percent was lower (P &amp;lt; 0.001) in the GH-treated group. These effects were independent of estrogen exposure and were still apparent in girls that had finished GH treatment at least 1 yr previously.<\/jats:p>\n                  <jats:p>Conclusions: Although GH treatment has little effect on cortical or trabecular BMD in girls with TS, it is associated with increased lean body mass and reduced adiposity.<\/jats:p>","DOI":"10.1210\/jc.2006-1351","type":"journal-article","created":{"date-parts":[[2006,8,30]],"date-time":"2006-08-30T04:31:02Z","timestamp":1156912262000},"page":"4302-4305","source":"Crossref","is-referenced-by-count":61,"title":["The Effects of Growth Hormone Treatment on Bone Mineral Density and Body Composition in Girls with Turner Syndrome"],"prefix":"10.1210","volume":"91","author":[{"given":"Mim","family":"Ari","sequence":"first","affiliation":[{"name":"Developmental Endocrinology Branch, National Institute of Child Health and Human Development (M.A., V.K.B., C.A.B.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir K.","family":"Bakalov","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Branch, National Institute of Child Health and Human Development (M.A., V.K.B., C.A.B.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvimol","family":"Hill","sequence":"additional","affiliation":[{"name":"Warren G. Magnuson Clinical Center Radiology Department (S.H.), National Institutes of Health, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn A.","family":"Bondy","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Branch, National Institute of Child Health and Human Development (M.A., V.K.B., C.A.B.), Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613535171700_R1","first-page":"209","article-title":"Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark","volume":"26","author":"Nielsen","year":"1990","journal-title":"Birth Defects Orig Artic Ser"},{"key":"2020071613535171700_R2","first-page":"157","article-title":"Growth failure in early life: an important manifestation of Turner syndrome","volume":"57","author":"Davenport","year":"2002","journal-title":"Horm Res"},{"key":"2020071613535171700_R3","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1210\/jc.2004-2187","article-title":"Impact of growth hormone supplementation on adult height in Turner syndrome: results of the Canadian randomized controlled trial","volume":"90","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535171700_R4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1203\/00006450-200109000-00019","article-title":"Bone mineral density assessed by phalangeal radiographic absorptiometry before and during long-term growth hormone treatment in girls with Turner\u2019s syndrome participating in a randomized dose-response study","volume":"50","author":"Sas","year":"2001","journal-title":"Pediatr Res"},{"key":"2020071613535171700_R5","first-page":"861","article-title":"Turner syndrome adolescents receiving growth hormone are not osteopenic","volume":"76","author":"Neely","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535171700_R6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1046\/j.1365-2265.1997.2791084.x","article-title":"Bone mineral density in Turner\u2019s syndrome\u2013a longitudinal study","volume":"47","author":"Shaw","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613535171700_R7","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1359\/jbmr.2000.15.10.2005","article-title":"Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients","volume":"15","author":"Carrascosa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"2020071613535171700_R8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1507\/endocrj.50.263","article-title":"Bone mineral density in adult patients with Turner\u2019s syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies","volume":"50","author":"Suganuma","year":"2003","journal-title":"Endocr J"},{"key":"2020071613535171700_R9","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.1210\/jc.2004-0481","article-title":"Growth hormone therapy and bone mineral density in Turner syndrome","volume":"89","author":"Bakalov","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535171700_R10","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1210\/jc.2003-030913","article-title":"Selective reduction in cortical bone mineral density in Turner syndrome independent of ovarian hormone deficiency","volume":"88","author":"Bakalov","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535171700_R11","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1210\/jcem.86.12.8063","article-title":"Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography","volume":"86","author":"Bechtold","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535171700_R12","first-page":"904","article-title":"Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner\u2019s syndrome, and intrauterine growth retardation during the first year of treatment with GH","volume":"78","author":"Leger","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613535171700_R13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1542\/peds.110.5.889","article-title":"Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study","volume":"110","author":"Gravholt","year":"2002","journal-title":"Pediatrics"},{"key":"2020071613535171700_R14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/eje.1.02113","article-title":"Influence of two different GH dosage regimens on final height, bone geometry and bone strength in GH-deficient children","volume":"154","author":"Radetti","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2020071613535171700_R15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01955265","article-title":"Evaluation of cortical thickness and bone density by roentgen microdensitometry in growing males and females","volume":"155","author":"Zamberlan","year":"1996","journal-title":"Eur J Pediatr"},{"key":"2020071613535171700_R16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0002-9343(03)00364-4","article-title":"Bone mineral density and fractures in Turner syndrome","volume":"115","author":"Bakalov","year":"2003","journal-title":"Am J Med"},{"key":"2020071613535171700_R17","first-page":"52","article-title":"Influence of growth hormone on accretion of bone mass","volume":"58","author":"Monson","year":"2002","journal-title":"Horm Res"},{"key":"2020071613535171700_R18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2265.2002.01614.x","article-title":"The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study","volume":"57","author":"Lanes","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613535171700_R19","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000184619","article-title":"Bone mineral density of prepubertal age girls with Turner\u2019s syndrome while on growth hormone therapy","volume":"44","author":"Lanes","year":"1995","journal-title":"Horm Res"},{"issue":"Suppl B","key":"2020071613535171700_R20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1096-6374(98)80022-1","article-title":"The use of growth hormone in adults: a review of the last 10 years, the present and a perspective for the future","volume":"8","author":"Bengtsson","year":"1998","journal-title":"Growth Horm IGF Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/11\/4302\/9060874\/jcem4302.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/91\/11\/4302\/9060874\/jcem4302.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T20:54:26Z","timestamp":1594932866000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/91\/11\/4302\/2656405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-1351","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}